Sichuan Kelun Pharmaceutical (002422.SZ): Xituximab N01 injection approved for market launch.
Kolun Pharmaceutical (002422.SZ) announced that its subsidiary Sichuan Kolun Botai Biopharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical (002422.SZ) announced that its subsidiary Sichuan Kelun Botai Biopharmaceutical Co., Ltd.'s recombinant epidermal growth factor receptor (EGFR) human-mouse chimeric monoclonal antibody - cetuximab injection (formerly known as A140) (Detelai) has been approved by China's National Medical Products Administration (NMPA) for listing in China. It is indicated for use in combination with FOLFOX or FOLFIRI regimens for first-line treatment of RAS wild-type metastatic colorectal cancer, at a dose of 500mg/m2 once every two weeks, or an initial dose of 400mg/m2 followed by a maintenance dose of 250mg/m2 once a week.
Related Articles
HK Stock Market Move | CHERVON (02285) fell more than 5% in late trading, still up nearly 30% over the past five sessions; HSBC said the joining of Techtronic's former president is positive.
Micron Technology, Inc. (MU.US) has begun commercial production at India's first semiconductor assembly and test facility, with chip capacity expected to expand to hundreds of millions of units next year.
HK Stock Market Move | Raw milk prices have entered an upward cycle. YOURAN DAIRY (09858) rose over 3%, and CH MODERN D (01117) rose over 2%.
HK Stock Market Move | CHERVON (02285) fell more than 5% in late trading, still up nearly 30% over the past five sessions; HSBC said the joining of Techtronic's former president is positive.
Micron Technology, Inc. (MU.US) has begun commercial production at India's first semiconductor assembly and test facility, with chip capacity expected to expand to hundreds of millions of units next year.
HK Stock Market Move | Raw milk prices have entered an upward cycle. YOURAN DAIRY (09858) rose over 3%, and CH MODERN D (01117) rose over 2%.
RECOMMEND
